# What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial.

> PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42308137-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42308137-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42308137-semaglutide-v1.json
- Content SHA-256: `32a517611a06e7b9222f309e180e4fa6300345c5bae5097b846cdfa88974184f`

## Claims and source pins

### Headline

What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial. ([`pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba`](#source-pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba))

### Summary

PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba`](#source-pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba))

### Paragraph 1

PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba`](#source-pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba`](#source-pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba))

## Sources

<a id="source-pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba"></a>
- **What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial. · retained source version 1:2026-07-26:current:cc893d47a8ba0020a019a1c6566d448ab12e7ff7b028d907c439d3b5f3fa735a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42308137/) (`pubmed-observation-pmid-42308137-2026-07-26-cc893d47a8ba`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42308137-semaglutide-v1.json SHA-256: 32a517611a06e7b9222f309e180e4fa6300345c5bae5097b846cdfa88974184f.